Caplight Directory>Companies>PAGE Therapeutics AG-preview>Pagetherapeutics


PAGE Therapeutics AG

PAGE Therapeutics AG

Private
BaselHealthcare & Life Scienceshttps://pagetherapeutics.com/

Last Round

Seed

Oct 25, 2024

Momentum Score

25 /100

Company Overview

PAGE Therapeutics AG is a biotechnology company that operates a platform for oncology drug development intended to discover and commercialize anti-metastatic compounds.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

anti-metastatic therapymetastasis preventioncirculating tumor cellsCTCsCTC cluster disruptionsmall molecule drugsNa+/K+ ATPase inhibitorsdrug discovery platformpreclinical biotechoncology drug developmentsolid tumor therapydrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PAGE Therapeutics AG Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PAGE Therapeutics AG Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedOct 25, 2024
Early FundingMay 11, 2023
View all Funding Rounds

Key People

Founding team and executive leadership

Daniele Scarinci

Acting CEO

Executive Team

PAGE Therapeutics AG Investors

Notable investors and investment history

InvestorRounds
ETH ZurichEarly Funding, Seed
XGEN VentureEarly Funding, Seed
Kizoo Technology CapitalEarly Funding, Seed
Claris VenturesEarly Funding, Seed
View all Investors

PAGE Therapeutics AG Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PAGE Therapeutics AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PAGE Therapeutics AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range6
Year Founded2022
Last FundingOct 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.